The development of neural circuits relies on axon projections establishing diverse, yet well-defined, connections between areas of the nervous system. Each projection is formed by growth cones-subcellular specializations at the tips of growing axons, encompassing sets of molecules that control projection-specific growth, guidance, and target selection 1 . To investigate the set of molecules within native growth cones that form specific connections, here we developed growth cone sorting and subcellular RNA-proteome mapping, an approach that identifies and quantifies local transcriptomes and proteomes from labelled growth cones of single projections in vivo. Using this approach on the developing callosal projection of the mouse cerebral cortex, we mapped molecular enrichments in trans-hemispheric growth cones relative to their parent cell bodies, producing paired subcellular proteomes and transcriptomes from single neuron subtypes directly from the brain. These data provide generalizable proof-of-principle for this approach, and reveal molecular specializations of the growth cone, including accumulations of the growth-regulating kinase mTOR 2 , together with mRNAs that contain mTOR-dependent motifs 3,4 . These findings illuminate the relationships between subcellular distributions of RNA and protein in developing projection neurons, and provide a systems-level approach for the discovery of subtype-and stage-specific molecular substrates of circuit wiring, miswiring, and the potential for regeneration.
, together with mRNAs that contain mTOR-dependent motifs 3, 4 . These findings illuminate the relationships between subcellular distributions of RNA and protein in developing projection neurons, and provide a systems-level approach for the discovery of subtype-and stage-specific molecular substrates of circuit wiring, miswiring, and the potential for regeneration.
Neurons are cells with exceptional structure, characterized by large intracellular distances punctuated with molecular specializations dedicated to local functions. Key subcellular specializations in the establishment of nascent circuitry are growth cones (GCs) at the tips of extending axons 1 . Although the in vivo molecular diversity of neuron subtypes is now well appreciated 5 , the in vivo projection-specific molecular diversity of growth cones remains unknown and experimentally inaccessible with current approaches. To enable quantitative and systems-level subcellular readouts from distinct subtype-specific growth cones in the brain, we developed an experimental approach of growth cone sorting and 'subcellular RNA-proteome mapping' .
To purify GC subtypes from the brain, we fluorescently label neuron populations in vivo, from which we isolate total GCs by subcellular fractionation 6, 7 (Fig. 1a) . Isolated GCs display intact membranes, are enriched in GC marker proteins, and retain encapsulated sequencingquality RNA (Extended Data Fig. 1 ). To specifically purify fluorescently labelled GC subtypes from bulk-isolated GCs of the brain, we modified and optimized a fluorescence-activated cell sorter with custom optics and fluidics to sort and collect fluorescent GCs directly (see Methods).
To monitor and verify our ability to purify individual fluorescent GCs, we used mouse lines that ubiquitously express a variant of red or green fluorescent protein (RFP or GFP, respectively). GFP-and RFP-labelled brains were fractionated together, so that isolated GCs were either red or green, but not both. We loaded isolated GCs into the modified sorter, calibrated gating based on size-standard beads, and determined the optimal conditions for the separation of individual singlecolour GCs. To verify collection, we gated on fluorescence to collect green and exclude red GCs. By re-analysing the collected sample, we determined that we indeed isolated pure green GCs (Fig. 1) , establishing the conditions and feasibility for the use of this approach to isolate pure subpopulations of labelled circuit-specific GCs from the brain.
We present here the first, to our knowledge, application of circuitspecific GC sorting on the trans-hemispheric projection formed by callosal projection neurons 5, 8 . We specifically labelled upper-layer cortical neurons by in utero electroporation 9 in one hemisphere with a plasmid that expressed GFP. Three days after birth (postnatal day (P) 3), we purified trans-hemispheric GCs using GC sorting on the contralateral hemisphere, in which only growing callosal axons that have crossed the midline are fluorescent. Protein was extracted from sorted GCs, and analysed by mass spectrometry to reveal the GC sub-proteome, which we symbolize as {P} GC , of growing trans-hemispheric axons ( Fig. 2 and Supplementary Table 1) .
As anticipated, a large constituent of {P} GC comprises a nexus of cytoskeletal, membrane and signalling proteins, typically associated with GC functions in axon guidance 1 . Confirming readout specificity, GFP itself-the marker for selection-was also detected by mass spectrometry in sorted GCs. Beyond these, {P} GC displays a rich range of prominent functional complexes dedicated to anabolism and growth, as well as catabolism and turnover. Notably, {P} GC includes a distinct set of RNA-binding proteins with known dual roles in nuclear spliceosomes as well as cytosolic ribonucleoprotein particles, raising the possibility of novel RNA-binding complexes that regulate GC-localized RNA. The chaperonin complex, specialized in the folding of nascent actin and tubulin polypeptides into functional proteins 10 , is also robustly present in {P} GC . Together, these findings support local GC synthesis and turnover of proteins in vivo, including cytoskeletal elements, as suggested by in vitro studies 11, 12 . As a first biological investigation using the new ability to acquire stage-and circuit-specific subcellular molecular data from the brain, we asked to what extent the local transcriptome matches the local proteome in developing neuron projections in vivo. Pioneering studies detected mRNA transcripts in distal processes of cultured neurons 11, [13] [14] [15] , giving rise to the idea of local translation producing local sub-proteomes in different parts of the neuron 16 . To examine this in vivo, and to determine the extent to which this happens across gene groups, we combined newly developed subtype-specific GC sorting with subtype-specific neuron cell body sorting [17] [18] [19] . Performing these approaches in parallel, we obtained paired, quantitative, internally normalized sub-transcriptome and sub-proteome measurements from diametric GC and cell body (soma) compartments from the developing trans-hemispheric projection of upper-layer cortical neurons in vivo.
We labelled layer II/III neurons of the mouse sensorimotor cortex with membrane-RFP and nuclear-GFP by in utero electroporation. At P3, electroporated hemispheres were triturated into a soma suspension, and sorted for green fluorescence to collect labelled neuron somata.
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Contralateral hemispheres were fractionated to extract GCs, and GC-sorted for red fluorescence to collect corresponding transhemispheric axon GCs. We extracted RNA and protein from sorted GCs and their parent somata, and performed RNA sequencing (RNA-seq) and mass spectrometry to obtain paired measurements from the sub-transcriptomes {R} GC and {R} soma , and the sub-proteomes {P} GC and {P} soma (Fig. 3) . This workflow yielded a high-confidence dataset of 955 genes with quantified GC-to-soma ratios for RNAs and proteins (λ R and λ P , respectively). These values enabled us to map genes based on paired subcellular mRNA and corresponding protein distributions within the developing projection. This revealed pronounced divergence across gene groups, with distinct clusters emerging based on paired distributions (Extended Data Figs. 2-6, Supplementary Tables 2-7 and Supplementary Discussion).
A notable pattern in the clustering of λ R values emerged from RNA mapping. Although most transcripts are depleted from GCs, we observed that transcripts containing a non-canonical sequence, known as the 5′ terminal oligopyrimidine (TOP) motif 3 , display marked and consistent GC enrichment. Of the 83 TOP transcripts detected, most displayed trends of GC enrichment, with about half enriched with Fig. 1 | GC sorting. a, Schematic demonstrating two-colour small-particle sorting to separate GFP from RFP GCs. (1) Brains from a GFP and an RFP mouse were homogenized together. (2) Subcellular fractionation yields a GC fraction that contains red and green GCs. (3) GCs were sorted to collect pure green GCs from the mix. b, Small particle sorter plot of forward-and side-scatter of GC sample (blue) overlaid on size-standard beads (grey) for size comparison. Isolated GCs are sub-micrometre particles with a size range centred on 0.5 μm. c, Sorter plot of mixed GFP and RFP GC suspension (as schematized in a), showing separation of GCs into red and green populations. Collection gate to isolate pure green GCs is indicated. d, Collected GCs gated from c were re-analysed revealing GFP-specific GCs. Sorting enables specific purification of gated GCs. n = 3 independent biological replicates. The sub-proteome {P} GC of proteins detected by mass spectrometry from purified post-crossing upper-layer callosal GCs from P3 mouse brains.
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Letter reSeArCH statistical significance, whereas no TOP transcripts were significantly depleted from GCs (Fig. 4) . These results were further validated by quantitative PCR (qPCR) of select TOP and non-TOP reference transcripts, and TOP transcripts were directly visualized in GCs using single-molecule RNA in situ hybridization ( Fig. 4c and Extended Data Fig. 7) . Collectively, TOP transcripts account for approximately 80% of all significantly GC-enriched transcripts in the mapping dataset (Supplementary Table 4) .
Fewer than 100 genes produce transcripts with bona fide TOP motifs 20 . However, they collectively produce 5-20% of the total proteome of a cell 21, 22 . TOP transcripts encode the proteins of the translation machinery itself, most notably the protein subunits of ribosomes and translation initiation factors 3 . As such, their expression is tightly coupled to cellular growth. The TOP motif itself functions as the ON/OFF switch for translation, and is under the direct control of mTOR 3, 23, 24 , a hub kinase that integrates growth-factor signalling with the availability of nutrients, energy, and oxygen 25 . Although 99.8% of all transcripts respond to mTOR signalling with only modest (approximately 20%) changes in translation, TOP translation is fully mTORdependent in an all-or-none manner. By contrast, there is a small group of non-canonical transcripts that contain internal ribosome entry sites, or lack poly(A) tails, making their translation entirely mTORindependent 24 . Interestingly, this group is the diametric opposite of the TOP group in our dataset, comprising the most extreme outliers of soma enrichment (Fig. 4a, b) . These data reveal notable subcellular polarization of the transcriptome within growing projection neurons based on mTOR dependence for translation.
Given the degree of TOP mRNA enrichment in GCs, together with their strict dependence on mTOR for expression, we investigated whether developing projection neurons localize endogenous mTOR to their axon GCs, as previously suggested by overexpression 26 . We identify mTOR and the mTOR-binding proteins LARP1 and raptor as specifically enriched in GCs at levels comparable to the cardinal GC marker GAP43. LARP1 directly binds and regulates the TOP motif 4, 27 , whereas raptor is a key subunit of mTOR complex 1 (mTORC1) 23 . We directly visualized these proteins in callosal projection neuron GCs, and observed that mTOR, LARP1, and mTORC1 components specifically accumulate in dense local foci in the 'palms' and 'cuffs' of axon GCs ( Fig. 5 and Extended Data Figs. 8, 9 ). This pattern is distinct from the granular immunolabelling throughout the neuron of the mTORC2 marker RICTOR and the lysosome marker LAMP1. These data collectively indicate the existence of distinct subcellular foci of mTORC1, LARP1, and their target TOP mRNAs in the GCs of developing axon projections.
The presence of local mTOR foci in callosal projection neuron axon GCs prompted us to examine whether mTOR signalling is necessary for the formation of the trans-hemispheric projection itself during development. We investigated this in vivo using two genetic strategies. In one approach, we electroporated callosal projection neurons with a dominant-negative subunit of PI3 kinase 28 (PI3K-DN), a crucial growth-factor signalling pathway that activates mTOR. Compared to matched GFP-only controls, PI3K-DN causes pronounced perturbation in neuron migration, as reported previously 29 , as well as marked loss of callosal axon extension. In a parallel approach, we acutely knocked out mTOR by Cre electroporation in floxed-mTOR mice (mTOR-KO). mTOR-KO does not significantly affect migration, callosal projection neurons with nuclear-GFP (nuc-GFP; green) and membrane-RFP (mem-RFP; red) by in utero electroporation. Nascent callosal projection at P3 displays ipsilateral somata with green nuclei, and trans-hemispheric axons with red GCs. Scale bar, 600 μm and 100 μm (insets). b, Schematic of subcellular RNA-proteome mapping workflow: neuron labelling; postnatal harvesting; cell dissociation of ipsilateral hemispheres for sorting of GFP + cell bodies; subcellular fractionation of contralateral hemispheres to isolate GC fraction for RFP + GC sorting. c, FACS plots with gates for GFP + somata and RFP + GCs used to collect trans-hemispheric GCs and their parent cell bodies; RNA-seq and mass spectrometry yield paired measurements of sub-transcriptomes {R} GC and {R} soma , and sub-proteomes {P} GC and {P} soma , from which GC-over-soma ratios of mRNA (λ R ) and protein (λ P ) were calculated for each gene. n = 6 independent biological replicates, 3-6 litters each. Significance thresholds set to a 0.05 permutation-based false discovery rate (FDR). n = 6 independent biological replicates, 3-6 litters each. c, Single-molecule RNA in situ hybridization (red) for Rack1 (nonribosomal TOP), Rplp0 (ribosomal TOP), and control transcript Ppib (soma-mapped, canonical) on cultured callosal projection neurons labelled with membrane-GFP (green). Nuclei were stained with DAPI (blue). Scale bar, 10 μm. See Extended Data Fig. 7 for full set. A total of 92, 103 and 84 GCs were imaged for Rack1, Rplp0 and Ppib probes, respectively. n = 4 biological replicates from independent in utero electroporations. 
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Letter reSeArCH but instead, specifically prevents the extension of axons across the corpus callosum ( Fig. 6 and Extended Data Fig. 10 ), collectively confirming that mTOR signalling is necessary for trans-hemispheric axon growth. Together, these findings place mRNAs of the translation machinery, along with their obligate regulator, mTOR, at the leading edge of growing long-range axon projections. Without mTOR signalling, these projections fail to form. We propose a developmental interpretation for these observations, in which the supply of cellular translation machinery is coupled to axon extension through local signalling. This subcellular organization might be a transient feature of the axon-extension phase of projection neuron development, physically positioning mTOR at sites of most intense cellular growth. It is intriguing to speculate that mTOR foci in GCs might enable sensing of target-derived growth signals locally to globally coordinate transitions of the developmental program of a neuron driven by target-derived signals. It will be interesting to examine this non-standard developmental model directly, along with its implications for axon growth, and possibly regeneration 30 (see Supplementary Discussion). Finally, this new line of experimentation using subtype-specific GC sorting and quantitative subcellular RNA-proteome mapping provides a generalizable approach that enables molecular investigations that compare subtype-and stage-specific GCs, GCs from mutant, regenerative, non-regenerative, or reprogrammed neurons to discover molecular specificities behind circuit development, miswiring, and possibly regeneration.
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Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-018-0847-y. preparations. The GC marker GAP43 is a positive control for enrichment; the Golgi marker GM130 is a negative control. b, Quantification of GC enrichment expressed as band intensity ratios of GC fraction over input from blots in a, normalized to corresponding GAP43 ratio (marked by line). mTOR, LARP1, and raptor (mTORC1 marker) display high GC enrichment comparable to GAP43. TSC1, RICTOR (mTORC2 marker), and LAMP1 (lysosome marker) are present in GCs at comparable levels to actin and tubulin. Data are mean ± s.e.m. from n ≥ 3 independent fractionation experiments from distinct litters (n = 7 for mTOR; n = 5 for LARP1, raptor and RICTOR; n = 3 for LAMP1 and TSC1; n = 8 for TUBB3; n = 6 for ACTB and GM130). c, GCs from cultured callosal projection neurons immunolabelled for endogenous mTOR pathway proteins (red in overlays, heat-mapped in underlying panels). mTOR, LARP1, TSC1, and raptor appear in dense local foci within GCs. RICTOR and LAMP1 appear in fine granules distinct from GC foci. Bar (bottom right) indicates the heat-map colour range, and the 10-μm scale. See Extended Data Fig. 8 for full set. In total, 83 GCs were imaged for mTOR, 47 for LARP1, 42 for LAMP1, 49 for TSC1, 26 for raptor, and 30 for RICTOR, from a minimum n = 3 biological replicates from independent in utero electroporations.
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MethodS
Animals. Animal experimental protocols were approved by the Harvard University Institutional Animal Care and Use Committee, and complied with all relevant ethical regulations regarding animal research. Experiments using wild-type mice were performed on outbred strain CD1 mouse pups of both sexes (Charles River Laboratories). Mice ubiquitously expressing GFP ( Fig. 1 ) are from the transgenic strain B6 ACTb-EGFP (JAX stock 003291) expressing GFP under the CAG promoter 31 . Mice ubiquitously expressing RFP ( Fig. 1) correspond to a knock-in strain ubiquitously expressing the RFP variant tdTomato, under the CAG promoter from the ROSA26 locus. We created this strain by breeding Ai9 strain 32 (JAX stock 007909) females with Vasa-Cre strain (JAX stock 006954) males expressing Cre in embryonic germ cells 33 (leading to the removal of a floxed-stop cassette from the original conditional tdTomato knock-in allele) and cross-breeding the red progeny. Both GFP and RFP mouse lines were back bred into the FVB background (JAX strain FVB/NJ) by selecting for fluorescence for over seven generations. For conditional mTOR-knockout experiments ( Fig. 6 and Extended Data Fig. 10 ), we used floxed-mTOR mice (JAX stock 011009) homozygous for mTOR alleles harbouring loxP sites flanking exons 1-5 of the Mtor gene 34 . No statistical methods were used to predetermine sample size. All animals analysed were P3 or younger, thus no sex determination was attempted. Analyses are thought to include animals of both sexes at approximately equal proportions. Investigators were not blinded to allocation during experiments and outcome assessment unless stated otherwise. Expression plasmid pCAG-GFP 36 (gift from C. Cepko, Addgene plasmid 11150) was used for GFP control electroporations (used in Fig. 6 and Extended Data Fig. 10 ). The PI3K-DN plasmid was produced using the following cloning procedures: (1) PCR amplification of the open reading frame of the PI3K regulatory subunit 1 (Pik3r1, accession number: NM_001077495) from mouse brain cDNA; (2) site-directed mutagenesis using QuikChange (Agilent) to delete 36 internal residues (Q478-K513) corresponding to the catalytic subunit-binding site, thus producing the dominant-negative construct PI3K-DN, as previously reported 28 ; and (3) PI3K-DN was subcloned into pCAG-GFP in-frame with GFP, downstream of a 2A element to create a bicistronic expression vector producing GFP and PI3K-DN. Plasmid expressing Cre and GFP for electroporations into floxed-mTOR animals was produced equivalently by subcloning Cre downstream of GFP-2A in pCAG-GFP. In utero electroporation. Electroporations were performed in utero on embryonic day 15, as previously described 37 , resulting in specific expression of plasmid DNA in cortical layer II/III neurons, including inter-hemispheric projection neurons (upper layer callosal projection neurons). Dense DNA solution was injected into one lateral ventricle using a pulled glass micropipette. Five current pulses of 35 V were applied, targeting nascent sensorimotor areas of the cortical plate. After term birth, electroporated mouse pups were screened for unilateral cortical fluorescence using a fluorescence stereoscope. GC fractionation. GC fractions were obtained using modifications of methods described previously 6, 7 . In brief, forebrains of P3 mouse pups were rapidly chilled and homogenized in 0.32 M sucrose buffer supplemented with 4 mM HEPES, HALT protease and phosphatase inhibitors (Thermo), and 1 U ml −1 RNase inhibitors (Promega), with 13 strokes at 900 r.p.m. in a glass-Teflon potter. Postnuclear (input) homogenates were obtained as supernatants after centrifugation at 1,700g for 15 min. Inputs were layered onto 0.83 M sucrose and a 2.5 M sucrose cushion, and spun cooled in a fixed vertical rotor (VTi50, Beckman) at 250,000g for 50 min. The GC fraction was extracted from the 0.32-0.83-M interface. GC protection assays. To investigate the integrity of GCs in GC fractions, and the specific encapsulation of GC protein and RNA by continuous GC membrane, we applied two parallel hydrolytic enzyme 'protection assay' approaches. We performed protection assays with RNase (RNase One, Promega) to test for GC RNA protection, and with protease (trypsin) to test for GC protein protection. Test samples were incubated with either 0.025% trypsin or 30 U ml −1 RNase at 4 °C for 90 min with constant rotation. In parallel with test samples, positive control samples contained 0.3% Triton X-100 detergent in addition to enzyme to disrupt GC membrane integrity and allow RNase or protease access to RNA and protein both outside and inside GCs (Extended Data Fig. 1 ). Negative control samples contained detergent but no hydrolytic enzyme. Enzyme concentrations, conditions and durations were titrated for complete degradation of all protein and RNA in the Triton X-100-containing control samples, without observable loss in negative control samples.
RNA and proteins remaining after treatment and incubation were measured using capillary electrophoresis (2100 Bioanalyzer, Agilent) or standard western blot, respectively (Extended Data Fig. 1 ). RNA and protein signals that survived treatment in test samples represent molecules protected inside intact GCs. GC and soma sorting and collection. GC sorting. To isolate labelled GCs, we took a subcellular fluorescence-based sorting approach, similar in concept to the previously developed FASS approach for synaptosomes 38 . We customized a Special Order Research Program (SORP) FACSAriaII (BD Instruments) fluorescenceactivated sorter for small particle detection. Forward-and side-scatter were detected using a photomultiplier tube (PMT) and a 300 mW 488 nm laser with reduced beam height (6 ± 3 μm) and custom lens assembly with noise-reducing filter and pico-motor focus. Scatter measurements were based on signal peak height and plotted in log mode. Before loading GCs, bleach followed by filtered water was run through the fluidics for at least 20 min. GCs were loaded onto a cooled sample platform and sorted through a cuvette flow cell with a 70-μm nozzle running at 70 psi with PBS as sheath fluid fed through a 0.1-μm filter. Bulk GC fractions in sucrose were diluted 3-6-fold in PBS immediately before loading into the sorter. Comparing the forward-and side-scatter profile of particles in the GC fraction to sub-micrometre polystyrene size-standard beads (BD), most GCs ranged from 0.3 to 0.8 μm in diameter (Fig. 1b) , consistent with previous electron microscopic analysis of a heterogeneous bulk GC fraction 6 . Appropriate bead sizes were used to calibrate drop delays and collection parameters. Soma sorting. We isolated fluorescent somata of layer II/III inter-hemispheric projection neurons from electroporated hemispheres using established approaches 17, 19, 39 . The electroporated areas of the cortical plate were micro-dissected to remove meninges and the ventricular zone (VZ) under a fluorescence stereoscope (Nikon). The micro-dissected pieces of cortex containing fluorescent postmitotic neuron cell bodies were dissociated for sorting as previously described 17, 18, [39] [40] [41] . We used a different customized SORP FACSAriaII equipped with a 100 mW 488 nm laser with large beam height, and an 85 μm nozzle at 45 psi, to collect GFP-labelled neuronal somata (Fig. 3c) . Sorted GC-soma collection for downstream RNA-seq and mass spectrometry. We collected GCs directly into guanidinium-based buffer RLT (Qiagen) containing 2-mercaptoethanol. For each biological replicate, we used an average of 6 electroporated brains, from which we collected on average 2,000,000 fluorescent GCs, and 200,000 fluorescent parent cell bodies. Collection run times averaged 12 h for GCs, and 1.5 h for somata. In addition to electroporation, we tested and successfully sorted fluorescent GCs using alternative methods of fluorescent labelling, including conditional mouse lines, and lipophilic dyes. We extracted both RNA and protein from each sorted sample using a commercial column-based kit according to the manufacturer's protocol (AllPrep DNA/RNA/Protein kit, Qiagen). Total GC and total soma RNA samples were eluted into 14 μl H 2 O, and frozen until use for cDNA library preparation and RNA-seq. Total protein from GC and soma samples was precipitated, and pellets were frozen until processing for mass spectrometry. Mass spectrometry. Protein samples were subjected to on-pellet processing and liquid chromatography-tandem mass spectrometry (LC-MS/MS) on an LTQ Orbitrap Elite (Thermo Fischer) supplied by a NanoAcquity UPLC pump (Waters) for label-free quantitative mass spectrometry. Sample order was randomized between replicate experiments. Specifically, protein pellets were resuspended in 8 M urea, reduced at 56 °C with TCEP, alkylated with iodoacetamide, and digested for 4 h with trypsin. Remaining pellets were sonicated in 80% acetonitrile, and digested in trypsin overnight. Tryptic peptides were separated on a 100-μm microcapillary trapping column packed with 5 cm C18 Reprosil resin of 5 μm particles with 100 Å pores, followed by a 20 cm analytical column of Reprosil resin of 1.8 μm particles with 200 Å pores (Dr. Maisch GmbH). Separation was achieved with a 5-27% acetonitrile gradient in 0.1% formic acid over 90 min at 200 nl min
Peptides were ionized by electrospray with 1.8 kV on a custom-made electrode junction sprayed from fused silica pico tips (New Objective). The LTQ Orbitrap Elite was operated in data-dependent mode. Mass spectrometry survey scan was performed in the 395-1,800 m/z range at a resolution of 6 × 10 4 , followed by selection of the 20 most intense ions (TOP20) for collision induced dissociation (CID)-MS2 analysis in the ion trap, using a precursor isolation window width of 2 m/z, an AGC setting of 10,000, and maximum ion accumulation of 200 ms. Singly charged ion species were not subjected to CID fragmentation. Normalized collision energy was set to 35 V and an activation time of 10 ms. Ions in a 10 p.p.m. m/z window around ions selected for MS2 were excluded from further selection for fragmentation for 60 s. The same TOP20 ions were subjected to high collision energy dissociation (HCD)-MS2 analysis in the Orbitrap. The fragment ion isolation width was set to 0.7 m/z, AGC was set to 50,000, the maximum ion time was 200 ms, normalized collision energy was set to 27 V and 1 ms activation time for each HCD-MS2 scan. We analysed output data using MaxQuant and Perseus software (see 'RNA-proteome mapping data analysis'). RNA-seq. cDNA libraries from sorted GC and soma samples were prepared from equal masses of RNA using random hexamer primers depleted of rRNA sequences (Ovation Single Cell RNA-Seq System, Nugen). Sample order was randomized between replicate experiments. We prepared libraries according to the Letter reSeArCH manufacturer's protocol, using six amplification cycles to avoid over-amplification and signal saturation. GC and soma libraries were barcoded and sequenced together on an Illumina Hiseq 2500 sequencer, generating 100-bp paired-end reads. RNA-seq reads were processed using bcbio-nextgen v0.9.5, aligning to GRCm38 with the STAR aligner 42 and quantifying counts per gene with Sailfish 43 using the Ensembl annotation. We examined a variety of quality control metrics to detect poorly performing samples, using a combination of Qualimap 44 and FastqQC (Babraham Bioinformatics). RNA-proteome mapping data analysis. Replicates and quality control. When the amount of material permitted, we subdivided RNA and protein from a single biological replicate to perform technical replicate RNA-seq and mass spectrometry runs (duplicates or triplicates, depending on available material). Technical replicates included loading partial amounts (halves or thirds) to assess quantitative linearity of output measurements. Technical replicates confirmed low variance between instrument runs and quantitative linearity of readouts. Readouts from technical replicates were merged into a combined data set as a single biological replicate in subsequent statistical analyses.
Biological replicates were subjected to principal component analysis, and cross-correlation analysis. We did not further consider replicates that did not pass quality control tests or were consistent outliers, displayed low complexity, or exhibited identifiable library artefacts. Of the six biological replicates performed for each compartment, five GC RNA-seq, five soma RNA-seq, four GC mass-spec, and six soma mass spectrometry replicates passed quality control (Extended Data  Fig. 2 ). These readouts were considered further for quantification and subcellular RNA-proteome mapping. Individual values of each biological replicate for each gene can be accessed on the Harvard Dataverse repository. Label-free quantitative mass spectrometry analysis. Mass spectrometry readouts were analysed using the MaxQuant software package following the MaxLFQ method for label-free quantitative (LFQ) proteomics 45 . Mass spectra were assigned to corresponding peptides and proteins with a 7 p.p.m. peptide tolerance, and peptide-to-spectrum-match FDR of 0.05, and protein matching with a minimum of one unique peptide and FDR of 0.01 using the Andromeda search engine against version 83 of the Ensembl annotation. Proteins that were detected in the same compartment in at least two biological replicates were considered bona fide constituents of the sub-proteomes {P} GC and {P} soma (Supplementary Tables 2 and 3) .
For quantification of GC-to-soma ratios λ P , LFQ intensities for the proteins in {P} GC and {P} soma were extracted from MaxQuant to the Perseus Platform 46 for matrix processing and statistical analysis. Raw LFQ values were normalized across biological replicates of the same compartment using quartile alignment and width adjustment of distributions, so that distribution peaks align at 1. Values were log 2 transformed, and imputation was used to assign baseline non-zero values to represent lack of detection. Imputed values were randomly assigned from a distribution simulating baseline detection noise with a distribution peak downshifted by 2 standard deviations and a width of 0.25 standard deviations of the distribution of detected values. This provided non-zero values for ratiometric determination of λ P (GC mean normalized LFQ intensity over soma mean normalized LFQ intensity; Supplementary Table 2) . Volcano plots of GC-soma represent λ P values on the x axis, and two-tailed t-test values across biological replicates on the y axis. Significance thresholds were set to a 0.05 permutation-based FDR. RNA-seq quantitative analysis and proteome matching. RNA-seq data were internally filtered for transcripts that were detected in at least three of the five GC, or three of the five soma replicate datasets to produce bona fide sub-transcriptomes {R} GC and {R} soma . Sailfish 43 transcripts per million (TPM) counts for each gene were matched to the proteome dataset through Ensembl gene IDs, yielding 955 genes with complete RNA-proteome mapping data (Supplementary Table 4 ). Sailfish raw counts were analysed with Perseus similar to LFQ protein data. Values were quartile aligned with peaks at 1, log 2 transformed, and missing values were imputed from the noise, as above. Ratiometric determination of GC enrichment λ R (GC mean normalized TPM counts over soma mean normalized TPM counts), and GC-soma mapping volcano plots were performed as with proteins above. Gene annotation. RNA and protein sequences were aligned and paired using version 83 of the Ensembl annotation. Uniprot and RefSeq entries were matched to Ensembl gene ID using the Synergizer service 47 . Gene Ontology (GO) annotation was assigned based on the UniProt database. Ad hoc gene groups corresponding to cell compartments were annotated based on the COMPARTMENTS subcellular localization database 48 . Protein interactions were annotated based on version 10.0 of the STRING database 49 . RNA-protein annotation enrichment. 1D and 2D annotation enrichment analysis was performed as described 50 using the combined dataset of RNA-seq and mass spectrometry biological replicates as input. Annotations considered were GO terms from three categories ('molecular process' , 'biological function' and 'cellular component'), as well as gene groups as listed in Supplementary Table 7 . Significance was determined using a two-sided Benjamini-Hochberg corrected FDR of 0.02 (Supplementary Tables 3, 5 and 6 ).
RNA analyses. Native RNA gel electrophoresis. We loaded purified GC and input homogenate RNA with GelRed, and ran them on a native 1% agarose gel in TBE (89 mM Tris-HCl, pH 7.8, 89 mM borate, 2 mM EDTA) alongside single-strand RNA ladder (NEB). RNA capillary electrophoresis. We performed analysis of RNA on an Agilent 2100 Bioanalyzer following the manufacturer's protocol. For mRNA-specific profiles, we used oligo (dT) 25 beads to purify polyA-containing transcripts before analysis.
RT-PCR.
We used equal masses of RNA from purified GC and input to make GC and input cDNA libraries, following manufacturer's instructions (SuperScript III, ThermoFisher). We performed PCR on GC and input cDNA sample templates, amplifying Actb and Gfap for 32 cycles with primer pairs according to PrimerBank 51 . We imaged amplicon bands using standard agarose electrophoresis. qPCR analysis. cDNA synthesis was performed on RNA purified from sorted GC and soma using SuperScript IV (ThermoFisher). qPCR analysis was performed on a BioRad CFX96 using the TaqMan Gene Expression Assay (Applied Biosystems, ThermoFisher) according to the manufacturer's protocol. The following TaqMan probes were used: Rplp0 (#4453320; Mm00725448_s1), Rpl18a (#4448892; Mm04205642_gH), Rpsa (#4448892; Mm00726662_s1), Rps24 (#4448892; Mm01623058_s1), Rack1 (Gnb2l1) (#4448892; Mm01291968_g1), Eef1b2 (#4448892; Mm00516995_m1), Eef1g (#4448892; Mm02342826_g1), Cdkn1b (#4453320; Mm00438168_m1), Hspa5 (#4453320; Mm00517691_m1), Ppib (#4453320; Mm00478295_m1), Tubb2b (#4448892; Mm00849948_g1), Actb (#4453320; Mm02619580_g1), Gap43 (#4448892; Mm00500404_m1). Relative abundance in each sample was normalized by the mean expression of all transcripts tested, and enrichment is reported as the mean of GC/soma ratios across three biological replicates from independent litters. Sample order was randomized between replicate experiments. Agreement between RNA-seq and qPCR enrichment was assayed by calculating R 2 , the square of Pearson's r, from log 2 -transformed normalized expression ratios. Neuron culture. We cultured neurons from newborn mouse pup cortices that had been electroporated in utero at embryonic day 15 to label layer II/III interhemispheric projection neurons. We cultured neurons isolated from electroporated areas of cortex on poly-d-lysine-coated glass coverslips for 2-3 days, as previously described 39 . Single molecule in situ hybridization. Single molecule in situ hybridization was performed using the RNAscope 2.5 HD RED kit according to the manufacturer's instructions (Advanced Cell Diagnostics). In brief, primary cortical neurons cultured on glass coverslips for 2-3 days (described above) were fixed in 4% paraformaldehyde for 30 min at room temperature, followed by a series of ethanol dehydration and rehydration steps, pretreated first with hydrogen peroxide for 10 min, then with protease III (1:50) for 10 min. After the pretreatment steps, coverslips were incubated with individual probes for 2 h and the standard RNAscope protocol was followed. Incubation time of amplification step 5 and colour reaction were optimized for each probe per the recommendations of the manufacturer. After rinses, coverslips were immunostained for GFP using the standard procedure (described below). RNAscope probes targeting RPLP0 (315411, Entrez Gene: NM_007475.5), RACK1 (443621, Entrez Gene: NM_008143.3), PPIB (313911, Entrez Gene: NM_011149.2) and negative control DapB (#310043) were used. Images were acquired on a Zeiss LSM 880 confocal microscope using a 63× objective. Outlines were created using Trace Contour filter on Adobe Photoshop CC 2017. Western blot. We performed western blots using standard Tris-glycine SDS-PAGE protocols. We determined total protein using the fluorometric Qubit protein assay (Thermo Fisher), and loaded equal amounts of total protein from input and GC fractions. We electroblotted resolved proteins onto PVDF membranes using semi-dry transfer. We followed standard western blot protocols, and incubated blots with primary antibodies diluted in 3% BSA in TBS with 0.2% Triton X-100, or in 'Can Get Signal' buffer (Toyobo). We used the following antibodies for immunoblotting: mouse-anti-β-actin, A5441, Sigma (1:2,000); mouse-anti-GAP43, MAB347, Chemicon (1:2,000); mouse-anti-GM130, 610823, BD Biosciences (1:3,000); mouse-anti-LAMP1, 1D4B, Developmental Studies Hybridoma Bank* (1:500); rabbit-anti-LARP1, #PA5-62398, ThermoFisher (1:1,000); mouse-anti-MAP2, #M1406, Sigma (1:1,000); rabbit-anti-mTOR, #2983, Cell Signaling Technology (1:1,000); rabbit-anti-mTOR, #A300-504A, Bethyl Labs (1:500); rabbit-anti-raptor, #42-4000, ThermoFisher (1:1,000); rabbit-anti-RICTOR, #2140, Cell Signaling Technology (1:1,000); rabbitanti-TSC1, PA5-20131, ThermoFisher (1:1,000); mouse-anti-tubulin, MMS-435P, Covance (1:2,000).
Isotype-specific secondary antibodies used for ECL imaging were HRPconjugated and cross-adsorbed (Life Technologies; Abcam). Immunoreactive bands were visualized through detection of chemiluminescence by SuperSignal West Pico PLUS (ThermoFisher) using a CCD camera imager (FluoroChemM, Protein Simple). To measure GC fraction enrichment, we quantified band intensities by densitometry, after applying despeckle filters using ImageJ software (NIH).
Within each biological replicate, we normalized enrichment ratios (GC/input) for each protein of interest to the enrichment of GAP43 (the cardinal GC marker used to assess the degree of enrichment in each GC sample) and calculated mean and standard error using these normalized values. We used densitometry values from n ≥ 3 independent fractionation experiments from distinct litters (n = 7 for mTOR; n = 5 for LARP1, raptor and RICTOR; n = 3 for LAMP1 and TSC1; n = 8 for TUBB3; n = 6 for ACTB and GM130) to calculate means and standard deviations of GC/input ratios. We normalized expressed ratios to GAP43 ratios, and we calculated statistical significance using one-way ANOVA and post hoc analysis using Student's t-tests. Immunolabelling and imaging. For imaging, cultured neurons were fixed after 3 days in vitro in 4% paraformaldehyde. Brains were prepared by intracardial perfusion with 4% paraformaldehyde, and cut on a vibrating microtome (Leica) into 80 μm coronal sections. Immunolabelling of both coverslips and brain sections was performed in 3% bovine serum albumin and 0.2% Triton X-100. We used the following antibodies for immunolabelling: chicken-anti-GFP, A10262, Invitrogen Isotype-specific secondary antibodies used for fluorescence imaging were Alexa Fluor-conjugated and cross-absorbed (Life Technologies). We acquired images on an epifluorescence microscope (Nikon 90i) with automated stage controller. Whole brain section images were generated using EDF z-stack projections and mosaic image stitching through the NIS Elements software (Nikon). In vivo PI3K-DN and mTOR cKO analysis. To analyse electroporation position, migration and callosal axon extension in electroporated brains (Fig. 6 and Extended Data Fig. 10 ), four different brains from three independent litters were used for each experimental group. Animals for control and test electroporations were assigned at random, within the appropriate cohorts of experimental strains. Brain sections were immunostained against GFP, and imaged using an epifluorescence microscope (Nikon 90i). Images were used for quantifications as detailed below. Where counting was manual, obviously discernible phenotypes prevented effective blinding, thus a strict standardized process for measurement was used across samples. For quantification of migration, four different brains per condition were used, with minimum four sections per brain, with two non-overlapping rectangular areas (medial and lateral to midline, covering the entire cortical column) per brain section (average approximately 155 GFP + cells per section, median 156 GFP + cells per section). Each area was divided into 10 horizontal parallel bins, and the number of GFP + cells was manually quantified. The percentage of GFP + cells occupying the top three bins versus the percentage occupying the lower seven bins was plotted (Fig. 6a and Extended Data Fig. 10c ). For quantification of alignment of electroporation areas and the extent of trans-hemispheric axon growth, four different brains per condition were used, with one section per brain (corresponding to sensorimotor area) used. Fiji was used for generation of bins in selected regions of interest and downstream automated intensity measurements 52 . For electroporation area measurements, a rectangular box covering the entire neocortical grey matter of the electroporated hemisphere (white matter cropped out before the measurement) was selected, binned into 200 parallel bins for intensity measurements, the background subtracted, and each bin normalized to the total intensity of the section. For callosal axon growth, rectangular boxes covering the entire callosum, centred to the midline, were selected, GFP + cell bodies were manually removed, and the field divided into 400 bins for intensity measurements. After background intensity removal, the intensity of each bin was normalized to the average intensity of the first five bins of the same section. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated and analysed during the current study are available in the Harvard Dataverse repository https://doi.org/10.7910/DVN/ISOEB6. Fig. 1 | Isolated GC verification. a, Enrichment analysis of GC fraction versus starting homogenate (input). Left, western blot detects protein enrichment of GAP43 (GC marker) and depletion of MAP2 (somato-dendritic protein marker) in GC fraction. Middle, native gel electrophoresis shows de-enriched presence of large (28S) and small (18S) ribosomal subunit rRNA in GC fraction. Right, RT-PCR detects mRNA for Actb (ubiquitous) but not Gfap (progenitor and glial marker) from the GC fraction. n = 6 biological replicates for protein and rRNA; n = 3 for mRNA. b, GC protection assay schema: bulk GC fraction isolated after subcellular fractionation is a suspension of GC particles enclosing GC-specific molecules (blue) within a medium that contains dilute soluble cytosolic molecules (red). Treatment with RNase or protease leads to hydrolysis of RNA and protein in the suspension medium not protected within GC particles, leaving only the GC-protected molecules (blue) after treatment. Addition of detergent before treatment results in hydrolysis of both cytosolic as well as GC-encapsulated molecules due to ruptures in the encapsulating GC plasma membrane, providing a control for the efficiency of enzymes. The difference in RNA or protein signal between hydrolysis control and GC-protected samples corresponds to the GC-encapsulated signal. c, d, GC protection assays with non-membrane-permeable degrading enzymes (protease in c and RNase in d) to test GC integrity and GC-specific membrane encapsulation of RNA and proteins in isolated GCs. Treatment with enzyme plus detergent, but neither alone, completely abolishes RNA and protein signal from GC fractions. Signals persisting in treatments with enzyme alone (lanes 3) correspond to RNA and protein encapsulated (protected) by the GC membrane, and correspond to the specific molecular content of isolated GCs. Treatment with protease alone has no effect on the signal from GAP43, confirming GC-specificity. Conversely, the signal from GM130, a Golgi matrix protein known to be excluded from GCs, is abolished with protease treatment alone, indicating there is no non-specific encapsulation in GCs. Reduced presence of both Actb and rRNA in samples treated with enzyme alone is consistent with their ubiquitous presence in both GCs and elsewhere in the homogenate. n = 5 independent biological replicates. e, Bioanalyzer profiles show GCprotected RNA compared to detergent-treated control, with characteristic peaks corresponding to 28S and 18S rRNA, and a spectrum of low intensity signal characteristic of mRNA. Experiments performed in n = 5 biological replicates with consistent results. Fig. 3 | Sorted GC-soma protein mass spectrometry intensities. Scatter plot of paired protein intensities from transhemispheric sorted GC and sorted parent somata. Units represent log 2 -transformed peak-normalized intensities as measured by MaxLFQ 45 . Gene groups are coloured as indicated in the key. The GC marker GAP43 is indicated by a circled asterisk. Fig. 5 | Sorted GC mRNA-to-protein distribution. Scatter plot pairing mRNA and corresponding protein relative abundance in trans-hemispheric-sorted GCs. Units represent log 2 -transformed peaknormalized mean intensities as measured by Sailfish TPM (mRNA) and MaxLFQ (protein) from 6 biological replicates of 3-6 litters each. Gene groups are indicated. The GC marker GAP43 is indicated by an asterisk. Trans-hemispheric GCs contain mRNA of select high-abundance GC proteins, as well as of most ribosomal protein mRNAs, whereas ribosomal proteins remain at GCs at moderate levels. Fig. 6 | Subcellular RNA-proteome mapping. 2D RNA-proteome mapping of statistically significant enrichments (twotailed t-test P value, significance threshold of 0.02 Benjamini-Hochberg corrected FDR, from 6 biological replicates of 3-6 litters each) in Gene Ontology (GO) terms and gene groups defined in Supplementary Table 7 . Labels are displayed for non-redundant GO cell compartment terms and gene groups. Histograms along the x axis show RNA distributions of log 2 -transformed mean λ R values. Histograms along the y axis on the right side show protein distributions of log 2 -transformed mean λ P values of genes within each group. Four clusters emerge: the soma cluster (blue) contains groups of genes with both mRNA and protein enriched in the soma; the anterograde cluster (red) contains groups of genes with mRNA mapping to soma and protein to GC; the mito cluster (grey) contains mitochondrial genes with intermediate distributions; and the TOP cluster (green) exclusively contains TOP transcripts (including ribosomal protein genes), with mRNAs mapping to the GC and proteins to both GC and soma. Fig. 7 | Subcellular transcriptome distribution follows mTOR dependence. a, Sample transcripts from each class represented in Fig. 4 were verified by qPCR (y axis), and correlated with RNA-seq mapping values (x axis). Measurements from the two approaches displayed strong concurrence, with correlation coefficient R 2 = 0.736. Centre points denote the mean, and error bars denote s.e.m. of three biological replicates from independent litters. Colour legend and schematics of mRNA classes based on known mTOR dependence: mRNAs containing a TOP motif are mTOR-dependent (green); schema indicates direct binding of the TOP motif by LARP1, which interacts with mTOR. mRNAs containing internal ribosome entry sites or lacking poly(A) tails are mTOR-independent (blue). Canonical mRNAs that undergo cap-dependent translation (grey) display moderate responses to mTOR. c, Expanded dataset presented in Fig. 4c . Single-molecule RNA chromogenic in situ hybridization (ISH, red) of two TOP transcripts: Rack1 (non-ribosomal TOP) and Rplp0 (ribosomal TOP), compared to a control transcript Ppib (soma-mapped canonical) in callosal projection neurons. Neurons were labelled with mem-GFP (green) via in utero electroporation at embryonic day (E) 15, cultured at P0, fixed and hybridized at in vitro day (DIV) 2-3. Nuclei were stained with DAPI (blue). Soma and GC close-ups shown in insets as overlays of transcript (red) with mem-GFP (green) in top rows, or with traced GC outlines in bottom rows. 92, 103 and 84 GCs imaged for Rack1, Rplp0 and Ppib probes, respectively, from n = 4 biological replicates from independent in utero electroporations. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
No custom code was used. MaxQuant (for mass-spec) and Perseus (for RNA-seq and mass-spec data analysis), Andromeda (for matching mass-spec spectra to peptide sequences), bcbio-nextgen v0.9.5, STAR aligner, Sailfish, Qualimap39 and FastQC (RNAseq analysis), The Synergizer database (for matching Uniprot and RefSeq entries to Ensembl IDs), the String database (for annotation of protein interactions), PrimerBank resource (for designing RT-PCR primers), Microsoft Excel Mac 2011, ImageJ-FIJI 2.0, Adobe Photoshop CC 2017, Apple Keynote (for image processing, intensity quantification and figure design). See methods for further details.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All studies must disclose on these points even when the disclosure is negative.
Sample size
Sample sizes were chosen based on preliminary experiments so as to provide sufficient material for downstream assays and power for statistical comparison (where appropriate).
We performed various optimizations for growth cone and soma FACS-sorting (for downstream RNA-seq and mass-spec) to find the optimal minimum amount of material needed. For each biological replicate, we used an average of 6 electroporated brains, from which we collected on average 2,000,000 fluorescent GCs, and 200,000 fluorescent parent cell bodies.
In accordance with standard procedures in the field, we performed all the experiments with at least three independent biological replicates (including western blot, RNA and protein protection assays, qPCR, in vitro immunocytochemistry, single molecule in situ hybridization, and in vivo manipulation of mTOR).
Data exclusions A standardized set of criteria were determined during the quality control process, which directly followed data acquisition, and always preceding measurements of data variables. In cases where a sample did not meet the quantified QC criteria, it was excluded from further analysis. All exclusions are explicitly detailed in the manuscript, including information on the number of initial samples and number of samples excluded, as well as detailed information on the QC parameters that specified their exclusion.
For RNAseq and mass-spec from GC sorting, biological replicates were subjected to principal component analysis, examination for identifiable library artifacts and contaminants, and cross-correlation analyses, as detailed in the methods. Of the six biological replicates performed for these analyses, five "GC RNA-seq", five "soma RNA-seq", four "GC mass-spec", and all six "soma mass-spec" replicates passed QC, as detailed in the manuscript. Within each RNA-seq and mass-spec readout, genes that were detected at least twice in independent biological replicates were considered bona fide constituents of the sub-proteomes or sub-transcriptomes, and were included in subsequent quantifications of the RNA-seq and mass-spec readouts, as detailed in the manuscript.
For western blotting of unsorted growth cone and post-nuclear homogenate, successful isolation of GCs was determined by Gap43 enrichment as an a priori criterion. Samples for which no enrichment of Gap43 was observed (GC/PNH < 1.2) were deemed to have failed, and were not included in downstream analysis of protein enrichment.
For in vivo manipulation of mTOR and PI3K, we excluded the samples that either 1) had a relatively poor electroporation due to incorrect embryonic stage (i.e. E16 rather than E15), or 2) failed to be sectioned at a proper angle on the microtome.
Replication
During optimization of the growth cone (GC) sorting, to rigorously verify our ability to purify individual fluorescent GCs ("singlets"), and not aggregates of heterogeneous GCs (i.e. doublets or higher order aggregates), we used two mouse lines either expressing a variant of red fluorescent protein (RFP) or a green fluorescent protein (GFP), and mixed GFP and RFP labeled brains together during homogenization, so that every GC in the suspension was either red or green, but never both. This control allowed us to establish standardized handling, conditions, timing, gating, and detector settings across all replications of GC sorting.
For GC sorting and RNAseq and mass-spec experiments, six independent biological replicates, each from multiple mouse litters, were performed and independently analyzed by RNA-seq and mass-spec. Standard for the mass-spec literature, two replicates are acceptable if the overlap between them is good. To investigate the reproducibility of RNA-seq results by other methods, we performed qPCR on select transcripts that covered the spectrum of RNA-seq results, from independent GC-soma sorting experiments and independent library preparations. The qPCR experiments were compared to RNA-seq results, and yielded a high R sq. correlation coefficient of 0.736, indicating high reproducibility with independent trials and with independent methods. For RNAseq and qPCR experiments, all replication attempts were successful.
To measure GC fraction enrichment of proteins of interest, we quantified band intensities of a minimum of 3 biological replicates to calculate means and standard error of GC/input ratios. Biological replicates were derived from independent litters of mice, and prepared separately. They were additionally loaded side-by-side on the same gels to allow for direct comparison and quantification under the same exposure
Validation
The antibodies used in the study have been used and reported previously in other published studies. Details regarding specific methods of validation for each antibody are as follows:
mouse-anti-beta-actin (#A5441, Sigma) The manufacturer provides positive and negative control data on western blot assay; single band for the positive control, no signal for the negative control. The antibody is well-validated by large number of studies including knock-down assays e.g. 
